Pricing Log in Create free account

Azitra, Inc. (AZTR) vs Liminatus Pharma Inc. (LIMN)

Azitra, Inc. and Liminatus Pharma Inc. are both Biotechnology companies. Azitra, Inc. and Liminatus Pharma Inc. are of similar size ($4.3M and $4.3M). Liminatus Pharma Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.0×. Across the 10 metrics below, Azitra, Inc. leads on 6 and Liminatus Pharma Inc. on 4.

Valuation

Metric AZTR LIMN Biotechnology median
P/E 1.05 n/m 8.50
P/S 2.33 n/m 9.71
P/B 0.18 9.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.48 n/m 0.64
EV/Sales (9.26) n/m 9.21
Earnings yield 95.57% (773.03%) (33.15%)
Free cash flow yield (842.70%) (135.00%) (25.50%)

Profitability

Metric AZTR LIMN Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) 294.43% (56.36%)
Return on assets (190.69%) (471.47%) (48.04%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR LIMN Biotechnology median
Revenue growth (TTM) 58.18% — 6.02%
EPS growth (last fiscal year) 85.67% (112.19%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric AZTR LIMN Biotechnology median
Debt to equity 0.00 4.80 0.00
Current ratio 4.86 1.12 4.72
Net debt to EBITDA 0.20 (0.37) 0.96

Dividend

Metric AZTR LIMN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AZTR LIMN Biotechnology median
Market cap 4.33m 4.32m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack